NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

 20 March 2026

Triton Investments Advisers LLP ("Triton")

No intention to make an offer for Spire Healthcare Group plc ("Spire Healthcare" or the "Company")

Further to the announcement made by Spire Healthcare on 18 February 2026 regarding the discussions between Triton and the Company in the context of the strategic review announced by Spire Healthcare on 18 September 2025, Triton confirms that it does not intend to make a firm offer for Spire Healthcare. 

This is a statement to which Rule 2.8 of the Code applies. Accordingly, Triton and any person(s) acting in concert with it will, except with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel"), be bound by the restrictions set out in Rule 2.8 of the Code.

Under Note 2 on Rule 2.8 of the Code, Triton, and any person(s) acting in concert with it, reserve the right to set the restrictions in Rule 2.8 aside in the following circumstances:

(a)      with the agreement of the board of directors of Spire Healthcare;

(b)      following the announcement of a firm intention to make an offer for Spire Healthcare by, or on behalf of, a third party, including Bridgepoint Advisers Limited;

(c)      following the announcement by Spire Healthcare of a Rule 9 waiver proposal (see Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

(d)      if there has been a material change of circumstances (as determined by the Takeover Panel).

Important notices

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise.

The distribution of this announcement in jurisdictions other than the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore, any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of Spire Healthcare who are not resident in the United Kingdom will need to inform themselves about, and observe, any applicable requirements.